| Name | Title | Contact Details |
|---|
Ohara LLC is a Sioux Falls, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our vision is a world where genomic information is fully accessible, understandable and integrated into health and well being. We are on a mission to help patients and healthcare providers use genetic services to improve health, lower the cost of care, and prevent disease.
Healthcare is changing. Healthcare organizations are growing. Care continues to expand outside of the hospital walls. This provides more capacity to utilize scale to create healthcare companies that are better functioning, smarter organizations. Intra-company logistics - the enterprise-wide movement of physical materials, such as blood and specimens, pharmaceuticals and supplies - is the foundation of the healthcare supply chain. Healthcare organizations, especially those providing service to patients` homes, need transportation to function. With 130+ locations in 29 states, MedSpeed is the market-leading organization that is changing the way the healthcare industry views transportation by leveraging it to help organizations integrate and operate more effectively.
Canadian Dental Service Plans Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).